
Affiliated with a Castle Connolly Top Hospital
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
For detailed information, please contact Dr. Sunwoo's office.
Alignment Health Plan
All Other Third Party
AllCare Health Plan
Blue Shield of California
Centene
Central California Alliance for Health
CVS Health (formerly Aetna)
Medicaid
Medicare
UnitedHealthcare
View All Insurances
Among the most nominated for the Castle Connolly Top Doctor recognition in 2025
Best Doctors, Inc.
Top Doctors, Castle Connolly
Faculty Teacher of the Year, Dept. of Otolaryngology, Stanford Univer
Best Doctors in America
K08 Award, National Institutes of Health
Chief Resident Teaching Award, Washington University
Alpha Omega Alpha, Washington University
Young Investigator Award, American Head and Neck Society
Resident Research Award, Washington University
Louis and Dorothy Kovitz Prize in Surgery, Washington University
Sigma Xi, Brown University
Epstein-Barr Virus Nuclear Antigen 1
CANCER, 2014
Targeting CD137 enhances the efficacy of cetuximab.
The Jourl of clinical investigation
Cancer immunosurveillance and immunoediting by tural killer cells.
Cancer jourl, 2013
Modulation of tural killer cell antitumor activity by the aryl hydrocarbon receptor
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2013
Epigenetically mediated pathogenic effects of phenthrene on regulatory T cells.
Jourl of toxicology, 2013
Identification of human NK cells that are deficient for sigling adaptor FcR gamma
INTERTIOL IMMUNOLOGY, 2012
CD44+cells have cancer stem cell-like properties in sopharyngeal carcinoma
INTERTIOL FORUM OF ALLERGY & RHINOLOGY, 2012
The manipulation of tural killer cells to target tumor sites using magnetic noparticles
BIOMATERIALS, 2012
Effect of stimulation of tural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab
Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., Scheer
The CD47-sigl regulatory protein alpha
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2012
Targeted endoscopic salvage sopharyngectomy for recurrent sopharyngeal carcinoma
INTERTIOL FORUM OF ALLERGY & RHINOLOGY, 2012
Distal-less homeobox transcription factors regulate development
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2008
HLA alleles determine differences in human tural killer cell responsiveness and potency
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2008
Spontaneous regression of cutaneous head and neck melanoma
HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2008
Mycotic pseudoaneurysm of the interl maxillary artery - Case report and review of the literature
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2007
Arrested tural killer cell development associated with transgene insertion into the Atf2 locus
BLOOD, 2006
Inhibition of nuclear factor-kappa B
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005
Licensing of tural killer cells by host major histocompatibility complex class I molecules
TURE, 2005
Nuclear factor-kappa B is an important modulator of the altered gene expression profile
CANCER RESEARCH, 2004
Effects of pharmacologic antagonists of epidermal growth factor receptor
INTERTIOL JOURL OF CANCER, 2002
Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer
JOURL OF CLINICAL ONCOLOGY, 2001
Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma
INTERTIOL JOURL OF CANCER, 1999
Chromosome 8 allelic loss
JOURL OF THE TIOL CANCER INSTITUTE, 1996
CELL-CYCLE OSCILLATION OF PHOSPHATASE INHIBITOR
TURE, 1990
Epstein-Barr Virus Nuclear Antigen 1
CANCER, 2014
Targeting CD137 enhances the efficacy of cetuximab.
The Journal of clinical investigation
Cancer immunosurveillance and immunoediting by natural killer cells.
Cancer journal, 2013
Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2013
Impact of positron emission tomography
CANCER, 2013
Epigenetically mediated pathogenic effects of phenanthrene on regulatory T cells.
Journal of toxicology, 2013
Identification of human NK cells that are deficient for signaling adaptor FcR gamma
INTERNATIONAL IMMUNOLOGY, 2012
CD44+cells have cancer stem cell-like properties in nasopharyngeal carcinoma
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2012
The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles
BIOMATERIALS, 2012
Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab
Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., Scheer
The CD47-signal regulatory protein alpha
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2012
Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2012
ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness
CANCER RESEARCH, 2012
A cisplatin-resistant subpopulation of mesenchymal-like cells in head
CELL CYCLE, 2011
Distal-less homeobox transcription factors regulate development
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2008
Temporal Relationship Between Antitumor Necrosis Factor-alpha Antibody Therapy
LARYNGOSCOPE, 2008
HLA alleles determine differences in human natural killer cell responsiveness and potency
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2008
Spontaneous regression of cutaneous head and neck melanoma
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 2008
Mycotic pseudoaneurysm of the internal maxillary artery - Case report and review of the literature
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2007
Arrested natural killer cell development associated with transgene insertion into the Atf2 locus
BLOOD, 2006
Inhibition of nuclear factor-kappa B
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005
Licensing of natural killer cells by host major histocompatibility complex class I molecules
NATURE, 2005
Nuclear factor-kappa B is an important modulator of the altered gene expression profile
CANCER RESEARCH, 2004
Effects of pharmacologic antagonists of epidermal growth factor receptor
INTERNATIONAL JOURNAL OF CANCER, 2002
Transcript map of the 8p23 putative tumor suppressor region
GENOMICS, 2001
IL (interleukin)-1 alpha promotes nuclear factor-kappa B and AP-1-induced IL-8 expression
CLINICAL CANCER RESEARCH, 2001
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival
CLINICAL CANCER RESEARCH, 2001
Coexpression of proangiogenic factors IL
CLINICAL CANCER RESEARCH, 2001
Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer
JOURNAL OF CLINICAL ONCOLOGY, 2001
Homozygous deletions define a region of 8p23.2 containing a putative tumor suppressor gene
GENOMICS, 1999
Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma
INTERNATIONAL JOURNAL OF CANCER, 1999
Constitutive activation of transcription factors NF-kappa B, AP-1
MOLECULAR CARCINOGENESIS, 1999
Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p
ONCOGENE, 1999
Clinical correlations with allelotype in supraglottic squamous cancer
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1998
Chromosome 8 allelic loss
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996
Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer
GENES CHROMOSOMES & CANCER, 1996
CELL-CYCLE OSCILLATION OF PHOSPHATASE INHIBITOR
NATURE, 1990
